HypoCol (red yeast rice) lowers plasma cholesterol- A randomized placebo controlled study

Scandinavian Cardiovascular Journal

Volumn 44, Issue 4, 2010, Pages 197-200

  Bogsrud, Martin Prøven ^a   Ose, Leiv ^a   Langslet, Gisle ^a   Ottestad, Inger ^b   Strøm, Ellen Charlotte ^a   Hagve, Tor Arne ^a,c   Retterstøl, Kjetil ^a,d  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b OSLO METROPOLITAN UNIVERSITY   (Norway)

^c AKERSHUS UNIVERSITY HOSPITAL   (Norway)

^d Norwegian Medicines Agency   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; C REACTIVE PROTEIN; CHOLESTIN; CREATINE KINASE; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYPOCOL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MEVINOLIN; PLACEBO; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; BIOLOGICAL PRODUCT; CHOLESTEROL; GLUCOSE BLOOD LEVEL; GLYCOSYLATED HEMOGLOBIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; ARTICLE; BACKACHE; CAUCASIAN; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROHN DISEASE; DIARRHEA; DOUBLE BLIND PROCEDURE; DRUG CAPSULE; DRUG EFFECT; DRUG TOLERABILITY; FEMALE; FLATULENCE; GENERAL DISCOMFORT; GLUCOSE BLOOD LEVEL; HUMAN; HYPOCHOLESTEROLEMIC EFFECT; INFLUENZA; MALE; PATIENT COUNSELING; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; TRIACYLGLYCEROL BLOOD LEVEL; ADOLESCENT; AGED; BLOOD; DIET SUPPLEMENTATION; DOWN REGULATION; HYPERCHOLESTEROLEMIA; METABOLISM; MIDDLE AGED; NORWAY; TIME; TREATMENT OUTCOME; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; BIOLOGICAL MARKERS; BIOLOGICAL PRODUCTS; BLOOD GLUCOSE; C-REACTIVE PROTEIN; CHOLESTEROL; CHOLESTEROL, LDL; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; DOWN-REGULATION; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERCHOLESTEROLEMIA; MALE; MIDDLE AGED; NORWAY; TIME FACTORS; TREATMENT OUTCOME; TRIGLYCERIDES; YOUNG ADULT;

EID: 77954843369     PISSN: 14017431     EISSN: 16512006     Source Type: Journal    
DOI: 10.3109/14017431003624123     Document Type: Article

References (15)

1. Endo A. The origin of the statins. 2004. Atheroscler Suppl. 2004;5:125-130
2. Heber D, Yip I, Ashley JM, Elashoff DA, Elashoff RM, Go VL. Cholesterol-lowering effects of a proprietary Chinese red-yeast-rice dietary supplement. Am J Clin Nutr. 1999; 69:231-236
3. Liu J, Zhang J, Shi Y, Grimsgaard S, Alraek T, Fonnebo V. Chinese red yeast rice (Monascus purpureus) for primary hyperlipidemia: A meta-analysis of randomized controlled trials. Chin Med. 2006;1:4.
4. Lu Z, Kou W, Du B, Wu Y, Zhao S, Brusco OA, et al. Effect of Xuezhikang, an extract from red yeast Chinese rice, on coronary events in a Chinese population with previous myocardial infarction. Am J Cardiol. 2008;101:1689-1693
5. Liu L, Zhao SP, Cheng YC, Li YL. Xuezhikang decreases serum lipoprotein(a) and C-reactive protein concentrations in patients with coronary heart disease. Clin Chem. 2003; 49:1347-1352
6. Zhao SP, Liu L, Cheng YC, Shishehbor MH, Liu MH, Peng DQ, et al. Xuezhikang, an extract of cholestin, protects endothelial function through antiinflammatory and lipid-lowering mechanisms in patients with coronary heart disease. Circulation. 2004;110:915-920
7. Meizhen S, Linhua T, Jiamin C. The effect of xuezhikang (proprietary red yeast rice) on sugar and lipid metabolism in type II diabetes mellitus [Abstract]. 1998. Available from: http://www.hypocol.com/pdf/clinical-trials4. pdf.
8. Heber D, Lembertas A, Lu QY, Bowerman S, Go VL. An analysis of nine proprietary Chinese red yeast rice dietary supplements: Implications of variability in chemical profile and contents. J Altern Complement Med. 2001;7:133-139
9. Li YG, Zhang F, Wang ZT, Hu ZB. Identification and chemical profiling of monacolins in red yeast rice using high- performance liquid chromatography with photodiode array detector and mass spectrometry. J Pharm Biomed Anal. 2004;35:1101-1112
10. Svilaas A, Strom EC, Svilaas T, Borgejordet A, Thoresen M, Ose L. Reproducibility and validity of a short food questionnaire for the assessment of dietary habits. Nutr Metab Cardiovasc Dis. 2002;12:60-70.
11. Li Z, Seeram NP, Lee R, Thames G, Minutti C, Wang HJ, et al. Plasma clearance of lovastatin versus chinese red yeast rice in healthy volunteers. J Altern Complement Med. 2005;11:1031-1038
12. Merck & Co., INC. Mevacor (lovastatin) Prescribing Information. 2008. Report No.: 9844659. Available from: http://www.merck.com/product/usa/pi- circulars/m/mevacor/mevacor-pi.pdf
13. Li C, Li Y, Hou Z. [Toxicity Study for Monascus purpureus (Red Yeast) Extract]. Information of the Chinese Pharmacology Society. 1995;12:12.
14. Prasad GV, Wong T, Meliton G, Bhaloo S. Rhabdomyolysis due to red yeast rice (Monascus purpureus) in a renal transplant recipient. Transplantation. 2002;74:1200-1201
15. Becker DJ, Gordon RY, Halbert SC, French B, Morris PB, Rader DJ. Red yeast rice for dyslipidemia in statin-intolerant patients: A randomized trial. Ann Intern Med. 2009;150: 830-839.